Inventor
LOCHT CAMILLE
BE36 patents
⚠️ This page may combine multiple inventors who share the name “LOCHT CAMILLE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PASTEUR INSTITUT
15 patentsUS6841358B1Jan 11, 2005
Recombinant proteins of filamentous haemagglutinin of bordetella, particularly bordetella pertussis, method for producing same, and uses thereof for producing foreign proteins of vaccinating active principles
PASTEUR INSTITUT33 citations86
US7833699B2Nov 16, 2010
Detection of tuberculosis and infection by Mycobacterium tuberculosis using HBHA
PASTEUR INSTITUT23 citations83
US9730995B2Aug 15, 2017
Attenuated Bordetella strains
PASTEUR INSTITUT5 citations82
US11065276B2Jul 20, 2021
Mutant Bordetella strains and methods of use
PASTEUR INSTITUT5 citations78
US10682377B2Jun 16, 2020
Mutant Bordetella strains and methods of use
PASTEUR INSTITUT7 citations78
US11285201B2Mar 29, 2022
Attenuated Bordetella strains
PASTEUR INSTITUT1 citations71
US10610580B2Apr 7, 2020
Attenuated Bordetella strains
PASTEUR INSTITUT1 citations71
US10258681B2Apr 16, 2019
Attenuated Bordetella strains
PASTEUR INSTITUT1 citations71
US9180178B2Nov 10, 2015
Method of using attenuated bordetella strains
PASTEUR INSTITUT3 citations71
US6660261B1Dec 9, 2003
Bordetella strain expressing the FHA hybrid, liposomes and vaccines
PASTEUR INSTITUT10 citations69
US12403188B2Sep 2, 2025
Bordetella strains expressing serotype 3 fimbriae
PASTEUR INSTITUT0 citations61
US11446372B2Sep 20, 2022
Bordetella strains expressing serotype 3 fimbriae
PASTEUR INSTITUT1 citations61
US6949345B1Sep 27, 2005
Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin
PASTEUR INSTITUT5 citations60
US7829103B2Nov 9, 2010
Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same
PASTEUR INSTITUT1 citations48
US7659055B2Feb 9, 2010
Fragments of nucleic acids specific to mycobacteria which are members of the M. tuberculosis complex and their applications for the detection and the differential diagnosis of members of the M. tuberculosis complex
PASTEUR INSTITUT1 citations40
INST NAT SANTE RECH MED
6 patentsUS11110161B2Sep 7, 2021
Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
INST NAT SANTE RECH MED4 citations81
US10653765B2May 19, 2020
Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
INST NAT SANTE RECH MED3 citations81
US6472213B1Oct 29, 2002
Shuttle vectors for the introduction of DNA into mycobacteria and utilization of such bacteria as vaccines
INST NAT SANTE RECH MED5 citations68
US10420827B2Sep 24, 2019
Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
INST NAT SANTE RECH MED1 citations66
US11819545B2Nov 21, 2023
Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
INST NAT SANTE RECH MED0 citations60
US8986709B2Mar 24, 2015
Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
INST NAT SANTE RECH MED2 citations60
NAT UNIV SINGAPORE
3 patentsUS9655959B2May 23, 2017
Adenylate cyclase deficient bordetella strains
NAT UNIV SINGAPORE9 citations79
US10046044B2Aug 14, 2018
Prevention of pertussis using adenylate cyclase deficient Bordetella strains
NAT UNIV SINGAPORE2 citations68
US10369207B2Aug 6, 2019
Prevention of pertussis using adenylate cyclase deficient Bordetella strains
NAT UNIV SINGAPORE2 citations65